Use of recombinant human coagulation factor VIII-Fc fusion protein for treatment of hemophilia A containing inhibitors

• Main Authors: LIU YUANWU, WANG LIRUI, REN ZIJIA, ZHU LUYAN, GAN TAIPING, LI XUEQIN, MO WEICHUAN, ZHONG BIN, LIU SHUANG, CHEN XIN, WANG SHUYA, SU HONGSHENG, CHEN XIAN, LIN YADONG, WANG WENWEN, GAO JIE, CHEN LINGLING
• Format: Patent
• Language: Chinese; English
• Published: 02.05.2023
• Subjects: HUMAN NECESSITIES; HYGIENE; MEDICAL OR VETERINARY SCIENCE; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS

The invention provides an application of a recombinant human coagulation factor VIII-Fc fusion protein in preparation of a medicine for treating hemophilia A containing an inhibitor. 本申请提供了培重组人凝血因子VIII-Fc融合蛋白用于制备治疗含抑制物的血友病A的药物的用途。